<DOC>
	<DOCNO>NCT00164008</DOCNO>
	<brief_summary>The purpose trial see whether zoledronic acid well pamidronate treat low bone density heart lung transplant patient .</brief_summary>
	<brief_title>Comparison Pamidronate With Zoledronic Acid Transplant Related Bone Loss Prevention</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>reduce bone density indicate bone density T score &lt; 1.in either lumbar spine femoral neck undergone wait list heart lung transplantation receive adequate calcium vitamin D therapy provide write informed consent prior participation trial untreated hypogonadism , hypothyroidism hyperthyroidism acute major organ rejection intercurrent illness pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>